WSJ
4 months agoNovartis to Make Pluvicto Radioligand Therapy at Indianapolis Plant
Novartis received FDA approval to produce Pluvicto radioligand therapy in its Indianapolis facility.
This decision will expand production capacity to meet the growing demand for cancer patients in North America. [ more ]